Ventricular tachycardia after initiation of fingolimod

Fingolimod, a sphingosine-1-phosphate receptor modulator, is used for the treatment of relapsing-remitting multiple sclerosis. It is well known to cause bradyarrhythmias. We present a 63-year-old woman who was admitted to the hospital with sustained monomorphic ventricular tachycardia 2 weeks after...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMJ Case Rep
Prif Awduron: Elounais, Farah, Aburahma, Ahmed, Alkotob, Mohammad Luay, Al Hadidi, Samer
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2017
Pynciau:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5747764/
https://ncbi.nlm.nih.gov/pubmed/28954755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-221819
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg